Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
EOMES - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GBP5 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
BTN3A1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
GEO DataSets Gene Profile neighbors Chromosome neighbors
Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
GEO DataSets Profile neighbors
C14orf80 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
KLRC4-KLRK1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
MUS81 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
STYX - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
MIR7703 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
BTN3A2 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
HCP5 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
CXCL9 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
TAP1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
HLA-F - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
DOT1L - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
SCAMP1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
AK2 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
ETV7 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
HLA-C - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
LAT - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on